ArticleCancer research2025

Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.

Catriona A Ford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.